# QRXPHARMA LTD — Form D

QRXPHARMA LTD of NORTH SYDNEY NSW 2060, C3, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-30. The offering totals $12.4M, of which $12.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2009-12-30
- Form: D
- Accession: 0000950138-09-000848
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $12.4M
- Amount sold: $12.4M
- Investors: 526
- Date of first sale: 2009-12-15
- Revenue range: Decline to Disclose
- SEC file number: 021-137324

## Issuer

- Name: QRXPHARMA LTD
- CIK: 0001433008
- Entity type: Corporation
- Jurisdiction: AUSTRALIA
- Address: LEVEL 1, NORTH SYDNEY NSW 2060, C3, 00000
- Phone: 61294928021

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Peter W Campbell | Director | North Sydney, C3 |
| Peter W Farrell | Director | North Sydney, C3 |
| John W Holaday | Director | ROCKVILLE, MD |
| Gary W Pace | Director | San Diego, CA |
| Michael W Quinn | Director | North Sydney, C3 |
| Chris W Campbell | Executive Officer | North Sydney, C3 |
| John W Holaday | Executive Officer | ROCKVILLE, MD |
| Warren W Stern | Executive Officer | North Sydney, C3 |

## More

- [CIK 1433008 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1433008&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000950138-09-000848.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.